Effectiveness of an Interactive mHealth App (EVITE) in Improving Lifestyle After a Coronary Event: Randomized Controlled Trial

• DOI: 10.2196/48756
• Publication Date: 2024-04-22T14:00:32Z
• Authors: María Ángeles Ber...; German Calle; Alejandro Gutiérr...; Livia Luciana Ghe...; Celia Cruz-Cobo; Nuria Trujillo-Ga...; Amelia Rodríguez-...; Josep A Tur; Rafael Vázquez-Ga...; María José Santi-...
• Keywords: mHealth; Mediterranean Diet

Background Coronary heart disease is one of the leading causes mortality worldwide. Secondary prevention essential, as it reduces risk further coronary events. Mobile health (mHealth) technology could become a useful tool to improve lifestyles. Objective This study aimed evaluate effect an mHealth intervention on people with who received percutaneous intervention. Improvements in lifestyle regarding diet, physical activity, and smoking; level knowledge healthy control cardiovascular factors (CVRFs); therapeutic adherence quality life were analyzed. Methods was randomized controlled trial parallel group design assigned 1:1 either involving smartphone app (mHealth group) or standard care (control group). The used for setting aims, self-monitoring CVRFs using measurements records, educating access information their screens about lifestyles adhering treatment, giving motivation through feedback achievements aspects improve. Both groups assessed after 9 months. primary outcome variables Mediterranean frequency food consumed, patient-reported smoking, CVRFs, life, well-being, satisfaction. Results analyzed 128 patients, 67 61 group; most male (92/128, 71.9%), mean age 59.49 (SD 8.97) years. Significant improvements observed compared diet (mean 11.83, SD 1.74 points vs 10.14, 2.02 points; P<.001), consumption, activity 619.14, 318.21 min/week 471.70, 261.43 min/week; P=.007), up smoking (25/67, 75% 11/61, 42%; P=.01), 118.70, 2.65 111.25, 9.05 component 12-item Short Form survey (SF-12; 45.80, 10.79 41.40, 10.78 P=.02). Overall satisfaction higher 48.22, 3.89 46.00, 4.82 P=.002) usability high 44.38, 6.18 out 50 95.22, 7.37 100). Conclusions EVITE effective improving patients terms controlling overall excellent. Trial Registration Clinicaltrials.gov NCT04118504; https://clinicaltrials.gov/study/NCT04118504